Patients for Patient Safety US (PFPS US) Awarded a Generous Grant From an Anonymous Funder to Advance Diagnostic Safety

April 10, 2025 11:00 AM

Patients for Patient Safety US (PFPS US) announces today that it is the recipient of a generous $350,000 grant from an anonymous funder. This transformative award will significantly advance PFPS US's patient-led efforts to improve diagnostic safety and reduce preventable medical errors. The grant includes a 1:1 $50,000 matching initiative to encourage others to invest in our work."We are deeply grateful for the funder's commitment to advance...

Read more

Dr Hala Medical Aesthetics Introduces New Holistic Approach to Enhance Wellness and Beauty

April 10, 2025 10:00 AM

Dr Hala Medical Aesthetics is the first clinic to adopt a holistic wellness philosophy that synchronizes advanced medical aesthetic treatments with holistic practices in a refined beauty paradigm centered on internal and external well-being. This is an example of how the industry is redefining aesthetics where clients want more than superficial treatments. They want total revitalization.The philosophy of the clinic is that true beauty comes from...

Read more

The Longevity Center Now Offering PRP Facials & Microneedling for Natural Skin Rejuvenation

April 10, 2025 10:00 AM

At The Longevity Center, an integrative health clinic located in West Palm Beach, Florida, patients have a new treatment option for addressing issues with skin elasticity, clarity, and aging: PRP (Platelet-Rich-Plasma) Facial Injections and Microneedling. Used in conjunction, these treatments work with the body's natural healing systems to rejuvenate skin naturally and with minimal stress, resulting in the sort of high-impact results that can...

Read more

Black Book Research Announces 2025 Top-Rated Payer Enterprise Analytics Vendors Based on Client Satisfaction Scores

April 10, 2025 9:30 AM

Black Book Research™, an independent healthcare-centric market research and public opinion research company, has released the results of its 2025 survey assessing client satisfaction and performance outcomes for enterprise analytics software and services vendors supporting U.S. payers and managed care organizations.Based on feedback collected from 1,313 validated users representing 404 payer entities-including commercial health plans,...

Read more

US Med-Equip Expands to Colorado Springs to Strengthen Hospital Support in Western U.S.

April 10, 2025 9:00 AM

Hospitals across Colorado and the western United States now have faster access to lifesaving medical equipment as US Med-Equip (USME) - the nation's top-rated provider of medical equipment rentals, sales, service and asset management - opens a new branch in Colorado Springs. The expansion strengthens USME's ability to provide hospitals with the critical equipment they need on demand.The new branch will help hospitals in the region manage...

Read more

PatientView Ranks Gilead "Best" at ESG

April 10, 2025 8:50 AM

At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups representing more than 70 countries. In a new report from UK-based PatientView, we were ranked "best" at ESG by patient groups who work with us.About Gilead SciencesGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in...

Read more

Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile with a Once Daily Pill

April 10, 2025 8:10 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced new icotrokinra (JNJ-2113) data from a subgroup analysis of ICONIC-LEADa, the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis (PsO) to assess efficacy and safety of an orally delivered systemic therapy in adolescents and adults simultaneously.Data from an oral presentation at the 2025 World Congress of Pediatric Dermatology (WCPD) Annual...

Read more

CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%

April 10, 2025 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL) is thrilled to announce a 500% increase in online sales this past quarter, catapulting the company into a new phase of growth as it rides the tidal wave of a rapidly expanding global wellness economy.This milestone reflects the company's relentless focus on innovation, clean ingredients, and product efficacy. From cutting-edge CBD topicals to adaptogenic mushroom blends, CBDL is gaining significant traction...

Read more

Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue

April 10, 2025 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced it has entered into a definitive agreement to acquire Peek Healthcare Technologies, Inc. ("Peek"). Peek operates the Peek Meds Marketplace, a digital prescription shopping platform built to empower consumers with...

Read more

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

April 10, 2025 7:30 AM

CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biotech company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced financial results for the fourth quarter and full-year 2024 and provided a business update.Commenting on the quarter Dr. Alexander Zehnder, Chief Executive Officer of CureVac said:"The fourth quarter of 2024 marked a strong finish to a year of significant transformation...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Updates Investor FAQ In Response to Shareholder Interest in $15M+ Wattbike Acquisition

April 10, 2025 7:10 AM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today today announced that it had updated its investor FAQ in response to ongoing shareholder interest in its expected Wattbike acquisition.For more commentary, information and details on the rationale for and structure of the expected acquisition,...

Read more

CMS Chief Dr. Oz's AI Avatar Vision for U.S. Healthcare comes to life through Addison Care

April 10, 2025 7:00 AM

Electronic Caregiver Inc., a nationally recognized innovator in virtual care, proudly announces that its flagship solution, Addison Care, is already fulfilling the bold future envisioned by Dr. Mehmet Oz, newly appointed Administrator of the Centers for Medicare and Medicaid Services (CMS). In his inaugural meeting, Dr. Oz called for the widespread use of AI avatars in healthcare, citing them as a transformative, cost-effective way to expand...

Read more

Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

April 10, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report its first quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.Webcast: https://investors.modernatx.comThe archived webcast will be available on Moderna's website...

Read more

Bionic Bloom Presents: Cannadelic Miami 2025 Announces Featured Speaker-Heather Reilly Hiemstra

April 10, 2025 6:00 AM

Bionic Bloom, the nation's first legal psilocybin therapy center and Title Sponsor of Cannadelic Miami 2025, is excited to announce Heather Reilly Hiemstra, Founder and Chief Formulator of Rockstar Blends, as a featured speaker at this year's conference. Cannadelic Miami 2025 is scheduled for May 23-24, 2025, at the Miami Airport Convention Center.​ Instagram+6Rockstar Blends+6Rockstar Blends+6Heather Reilly Hiemstra is renowned for her...

Read more

Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025

April 10, 2025 6:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April 2025.The Company is going to host a conference call to discuss 2024 results as well as to provide an update on the concluded strategic review process. The conference call will be held in English.Webcast detailsDate: Thursday, 17 April 2025Time: 2.00 pm CEST (1.00 pm BST, 8.00 am ET)To join the...

Read more

How the DEA Is Trying to Railroad MMJ Biopharma Marijuana Cultivation in Defiance of Supreme Court Axon Ruling

April 10, 2025 5:00 AM

The Drug Enforcement Administration (DEA) is currently embroiled in a high-stakes legal battle with MMJ BioPharma Cultivation, a biopharmaceutical company developing marijuana-derived treatments for Huntington's Disease and Multiple Sclerosis. But beneath the surface of this dispute lies a broader constitutional crisis: the DEA appears to be ignoring a landmark Supreme Court decision in Axon Enterprise, Inc. v. FTC, effectively attempting to...

Read more

Cyanagen Strengthens Long-Standing Partnership With Bioz, Driving High Product Engagement Through AI-Powered Badges

April 10, 2025 4:00 AM

Bioz, Inc., a pioneering force in AI-driven scientific research tools, is excited to extend its collaboration with Cyanagen, reinforcing a shared commitment to innovation and research transparency. As an established Bioz partner, Cyanagen continues to harness Bioz Badges and advanced AI-powered analytics to maximize the visibility of its high-quality reagents and chemiluminescence products in scientific literature.Cyanagen's reagents are widely...

Read more

Genflow Biosciences PLC Launches New Development Program

April 10, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is excited to announce the launch of a new development program in ophthalmology, focused on advancing a novel gene therapy leveraging its proprietary Centenarian SIRT6 (cSIRT6). This therapy will utilize a specially designed non-viral vector engineered for precise delivery of Genflow's SIRT6 to the eye. The therapy...

Read more

Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update

April 10, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its 2024 Annual Report and provided a corporate update. In his annual letter to shareholders, Dr. Raghuram Selvaraju, chairman of the board of directors, emphasized the Company's operational achievements, pipeline momentum, and...

Read more

Strategic Reset: Health System's Critical Window to Act During the 90-Day Tariff Truce - Black Book Research

April 9, 2025 4:45 PM

In response to President Donald Trump's April 9 announcement pausing most new U.S. import tariffs for 90 days, Black Book Research has issued targeted guidance for healthcare CFOs, procurement executives, and strategic sourcing leaders. With elevated tariffs still anticipated on pharmaceuticals, medical devices, and healthcare IT infrastructure, this temporary reprieve provides a critical window for organizations to recalibrate cost structures,...

Read more